You get what you pay for: That old saw applies to most corners of American consumerism, but not to healthcare. Convincing people of that is tough.
You get what you pay for: That old saw applies to most corners of American consumerism, but not to healthcare. Convincing people of that is tough.
The research shows that most Americans believe more-expensive healthcare is usually better—an assumption that has become one major driver of unnecessary costs plaguing the U.S. healthcare system. And researchers say it will take more than just high out-of-pocket costs borne by consumers to change their views.
“People are afraid of the low-cost option because they are afraid of substandard care,” said Judith Hibbard, a senior researcher at the University of Oregon and renowned scholar on consumerism in healthcare, whose comments Tuesday came during a presentation in Chicago at the Operations and Technology Forum held by America's Health Insurance Plans.
The trick to alleviating the fear of lower-cost healthcare is to show Americans the cost of their care alongside the relevant quality rankings for potential providers they could visit. And many of the existing healthcare transparency tools could stand to improve in this regard, according to a study out Wednesday from Catalyst for Payment Reform, a not-for-profit organization that works on behalf of large employers and other healthcare purchasers.
Read the full story here: http://bit.ly/1aINrOv
Source: Modern Healthcare
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More